Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (USA)

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoPRIME DIVIDEND CORP. Monthly Dividend Declaration for Class A & Preferred Share
MoUS FINANCIAL 15 SPLIT CORP. Preferred Dividend Declared
MoFINANCIAL 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share
MoM SPLIT CORP. Monthly Dividend Declared for Class I and Class II Preferred Shares
MoNew Commerce Split: Commerce Split Monthly Payments Declared for Capital Share and Preferred Shares
MoNetcompany Group A/S: Transactions in connection with share buyback programme
MoNovo Nordisk A/S - share repurchase programme
Mo1847 Holdings LLC: 1847 Holdings Subsidiary Wolo Receives Approval of Amazon Brand Registry, Expanding E-Commerce Presence
MoAVAX One Technology Ltd.: AVAX One Announces Development of Initial 10 MW Tier 3 AI/HPC Powered Land in Alberta
MoAllogene Therapeutics, Inc.: Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
MoENvue Medical, Inc.: ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network
MoCytoDyn Inc.: CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
MoSAIC, Inc.: SAIC Awarded New $75.2M PRISM Task Order to Advance the Naval Air Systems Command's Mission-Critical Aviation Systems
MoA.P. Møller - Mærsk A/S: Transactions in connection with share buy-back program
MoNayax Ltd.: Nayax at the NAMA Show 2026: Turning Payment Complexity into a Competitive Edge
MoPharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order
MoHelus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
MoFiserv, Inc.: Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day
MoASML reports transactions under its current share buyback program
MoBioCardia, Inc.: BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
MoKyverna Therapeutics, Inc.: Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
MoEnlight Renewable Energy Ltd.: Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
MoLENZ Therapeutics, Inc.: LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ for the Treatment of Presbyopia in the United Kingdom
MoCalidi Biotherapeutics, Inc: Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
MoPhathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026